Cyclerion Therapeutics's total assets for Q were $8.90M, a decrease of -11.59% from the previous quarter. CYCN total liabilities were $700.00K for the fiscal quarter, a -45.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.